Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand’s COOL-AF registry

Fig. 1

Demonstrates oral anticoagulant (OAC) and antiplatelet prescription pattern among different groups of patients with atrial fibrillation and a non-gender CHA2DS2-VASc score of 2 or more. Group 1 = patients without history of coronary artery disease (CAD); Group 2 = patients with history of coronary artery disease (overall); Group 3 = patients who underwent percutaneous coronary intervention (PCI) with drug-eluting stent (DES) within 1 year; Group 4 = patients who underwent percutaneous coronary intervention with stent longer than 1 year; Group 5 = patients who experienced acute coronary syndrome (ACS) without receiving a stent; and, Group 6 = patients with coronary artery disease without history of acute coronary syndrome or receiving a stent

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us